NICEATM Requests Information on Technologies for Detection and Measurement of Botulinum Neurotoxin

Home / Community Blog / NICEATM Requests Information on Technologies for Detection and Measurement of Botulinum Neurotoxin

Community Blog

NICEATM Requests Information on Technologies for Detection and Measurement of Botulinum Neurotoxin

NICEATM requests available data and information on approaches and/or technologies currently used for detection and measurement of botulinum neurotoxin (BoNT). Submitted information will be used to assess the state of the science and determine technical needs for non-animal test methods used to detect the presence of BoNT and measure potency of BoNT preparations.

Respondents to this request should provide information on any activities relevant to the development or validation of alternatives to in vivo test methods currently used by federal agencies for regulatory and other decision contexts. NICEATM also requests available data from in vivo BoNT tests used for similar applications as the proposed alternative, such as distinguishing between BoNT serotypes in biological matrix samples or measuring the potency of therapeutic BoNT preparations.

The deadline for receipt of the requested information is July 11. More information is available on the NICEATM website.

Catherine Sprankle
Catherine Sprankle
Communications Specialist for NICEATM